BNP [nesiritide] as adjuvant therapy to preserve renal function and facilitate diuresis in hospitalized patients with heart failure

Trial Profile

BNP [nesiritide] as adjuvant therapy to preserve renal function and facilitate diuresis in hospitalized patients with heart failure

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2009

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Decompensated heart failure; Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Nov 2009 Additional lead trial investigator (Redfield MM) identified as reported by ClinicalTrials.gov.
    • 17 Nov 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top